POM-V Prescription Required

Tilmovet 100 mg/g Granules for Pigs

Active ingredient: Tilmicosin

Form

Powder

Species

Pigs

Manufacturer

Huvepharma NV

VMD MA No.

30282/5022

What it's used for

Cattle Treatment of bovine respiratory disease associated with Mannheimia haemolytica and Pasteurella multocida Treatment of interdigital necrobacillosis....

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Tilmicosin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Tilmovet 100 mg/g Granules for Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Cattle
Treatment of bovine respiratory disease associated with Mannheimia haemolytica and
Pasteurella multocida
Treatment of interdigital necrobacillosis.
Sheep
Treatment of respiratory tract infections caused by Mannheimia haemolytica and
Pasteurella multocida
Treatment of foot rot in sheep caused by Dichelobacter nodosus and
necrophorum.
Treatment of acute ovine mastitis caused by Staphylococcus aureus and Mycoplasma
agalactiae.

For oral administration after incorporation into feed.
The veterinary medicinal product should be administered to small quantities of feed for
immediate consumption by individual animals. For treatment of groups of pigs, use an
appropriate premix incorporated into medicated feedingstuff by an authorised feed
manufacturer. Pigs to be treated should be separated and treated individually. The required
quantity of the veterinary medicinal product should be thoroughly mixed into the daily ration
for each individual pig. The feed containing the oral granules should be provided as the sole
ration for the periods recommended.
AN: 03692/2023 and 03695/2023Page 4 of 6
Individual pigs should receive 16 mg tilmicosin per kg bodyweight, corresponding to 160 mg
veterinary medicinal product/kg bodyweight, once a day for 15 days. To ensure a correct
dosage, body weight should be determined as accurately as possible and the amount of feed
that the pig is likely to consume should be estimated. The correct quantity of the veterinary
medicinal product should be added to the estimated quantity of daily ration for each pig, in a
bucket or similar receptacle, and thoroughly mixed. The veterinary medicinal product should
only be added to dry non-pelleted feed.

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Tilmicosin is known to be toxic for horses. Do not allow horses or other equines access to
feeds containing tilmicosin.
Horses fed with tilmicosin medicated feeds may present signs of toxicity with lethargy,
anorexia, reduction of feed consumption, loose stools, colic, distension of the abdomen and
death.
AN: 03692/2023 and 03695/2023Page 2 of 6

Pigs:
Undetermined frequency (cannot
be estimated from available data)
Reduced food intake, food refusal
1
this effect is transient
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary
medicinal product. Reports should be sent, preferably via a veterinarian, to either the
marketing authorisation holder or the national competent authority via the national reporting
system. See the package leaflet for respective contact details.

If for an individual animal, feed intake is such that the recommended dosage is not reached,
medication should be carried out by parenteral treatment.
Repeated use of the veterinary medicinal product should be avoided by improving
management practices and thorough cleansing and disinfection.
Cross-resistance has been shown between tilmicosin and other macrolides (like tylosin,
erythromycin) or lincomycin. Use of the veterinary medicinal product should be carefully
considered when susceptibility testing has shown resistance to other macrolides or
lincosamides because its effectiveness may be reduced.

Special precautions for safe use in the target species:
Use of the veterinary medicinal product should be based on identification and susceptibility
testing of the target pathogen(s). If this is not possible, therapy should be based on
epidemiological information and knowledge of susceptibility of the target pathogens at farm
level, or at local/regional level.
Due to likely variability (time, geographical) in the occurrence of the resistance of bacteria for
tilmicosin, bacteriological sampling and susceptibility testing are recommended.
Inappropriate use of the veterinary medicinal product may increase the prevalence of
bacteria resistant to tilmicosin and may decrease the effectiveness of treatment with
tilmicosin related substances.
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG category)
should be used for first line treatment where susceptibility testing suggests the likely efficacy
of this approach.
Special precautions to be taken by the person administering the veterinary medicinal product
to animals
Accidental ingestion should be avoided by humans.
People with known hypersensitivity to tilmicosin or other macrolide antibiotics should avoid
contact with the veterinary medicinal product.
May cause sensitisation by skin contact. May cause skin and eye irritation. Avoid direct skin
contact. Personal protective equipment consisting of overalls, safety glasses and impervious
gloves should be worn when handling the veterinary medicinal product. Wash affected parts
if skin contact occurs. If accidental eye contact occurs, immediately rinse thoroughly with
water. In case of accidental ingestion, or if you develop symptoms following exposure such
as skin rash, seek medical advice immediately and show the package leaflet or the label to
the physician.
Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and
require urgent medical attention.
If the operations involve the risk of exposure to dust, wear either a disposable filter and half
mask respirator conforming to European Standard EN149 or a non-disposable respirator to
European Standard EN140 fitted with a filter to EN143. This warning is particularly relevant
to on-farm mixing, where the risk of exposure to dust is likely to be enhanced.
AN: 03692/2023 and 03695/2023Page 3 of 6
Special precautions for the protection of the environment:
Not applicable.
Other precautions
Not applicable.

Do not use simultaneously with other macrolides and lincosamides.
Do not use simultaneously with bacteriostatic antimicrobial agents.
Tilmicosin may lessen the antibacterial activity of β-lactam antibiotics.

Do not store above 30ºC. Store in the original container in order to protect from moisture.

Meat and offal: 21 days.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.